Search for the latest updates on cancer
News
Heat Biologics Amends Bladder Cancer Protocol for Early Advancement Into Phase 2 Clinical Studies GlobeNewswire via Yahoo! Finance - 58 minutes
- Amended Design Expedites Phase 1/2 Trial of Heat's Immuno-Therapy Bladder Cancer Product Candidate -- - Provides Accelerated Timeline to ...
Amgen blood cancer drug succeeds in late-stage study Reuters via Yahoo! News - 6 minutes
(Reuters) - Amgen Inc said a late-stage study found that its blood cancer drug helped patients live significantly longer without the disease ...
Manage alerts · Unsubscribe · Privacy Policy
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment